Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkeyS L Berg, F M Balis, C L McCully, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 25, 1999
2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary dispositionJ S Roth, C M McCully, F M Balis, et al.
Cancer Research|April 1, 1993
Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoamS Kim, S Khatibi, S B Howell, et al.
Cancer Research|October 15, 1991
Pharmacokinetics of pyrazoloacridine in the rhesus monkeyS L Berg, F M Balis, C L McCully, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysA A Hertler, D M Schlossman, M J Borowitz, et al.
Biochemical Pharmacology|November 2, 1993
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cellsP C Adamson, F M Balis, M E Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeysP C Adamson, F M Balis, C L McCully, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemiaF M Balis, C M Lester, G P Chrousos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Remission induction of meningeal leukemia with high-dose intravenous methotrexateF M Balis, J L Savitch, W A Bleyer, et al.
Pageof 23